Cyclodextrin - Global Stategic Business Report

The global market for Cyclodextrin was estimated at US$289.1 Million in 2024 and is projected to reach US$329.6 Million by 2030, growing at a CAGR of 2.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Cyclodextrin market.

Global Cyclodextrin Market - Key Trends & Growth Drivers Summarized

Why Is Cyclodextrin Becoming a Key Ingredient in Pharmaceuticals and Food Industries?

Cyclodextrin, a cyclic oligosaccharide derived from starch, has gained significant importance in pharmaceuticals, food processing, and cosmetics due to its ability to enhance solubility, stability, and bioavailability of active ingredients. It is widely used in drug formulations to improve the solubility of poorly water-soluble compounds, making medications more effective and easier for the body to absorb. Additionally, its non-toxic and biodegradable nature makes it an attractive alternative for encapsulating sensitive ingredients in functional foods and nutraceuticals.

The growing demand for clean-label and naturally derived ingredients in food and beverage products has also propelled cyclodextrin usage. It acts as a carrier for flavors, vitamins, and essential oils, preventing oxidation and extending shelf life. In cosmetics, cyclodextrin is used in skincare formulations to enhance the stability of active compounds, particularly in anti-aging and sun-protection products. As industries seek multifunctional and eco-friendly excipients, cyclodextrin is becoming an increasingly valuable ingredient across multiple applications.

What Are the Latest Innovations in Cyclodextrin Production and Applications?

Advancements in enzymatic bioconversion have significantly improved the efficiency and cost-effectiveness of cyclodextrin production. Researchers are optimizing enzyme fermentation techniques to increase yields and customize cyclodextrin structures for specific applications. Additionally, the development of chemically modified cyclodextrins, such as hydroxypropyl-β-cyclodextrin and sulfobutylether-β-cyclodextrin, has expanded their use in pharmaceuticals, allowing for targeted drug delivery and controlled release formulations.

Another key innovation is the integration of cyclodextrins in environmental applications, such as wastewater treatment and air purification. Their ability to trap and remove volatile organic compounds (VOCs) and heavy metals has led to increased adoption in filtration systems. In the pharmaceutical sector, cyclodextrin-based nanocarriers are being developed for precision drug delivery, enabling more effective treatments for conditions such as cancer and neurological disorders. As research into cyclodextrin applications continues, its role in advanced healthcare and industrial solutions is expected to grow.

How Are Market Trends and Regulatory Policies Impacting Cyclodextrin Usage?

Market trends indicate a rising preference for cyclodextrin-based formulations in personalized medicine and functional food products. The demand for non-GMO, gluten-free, and allergen-free ingredients has positioned cyclodextrin as an ideal stabilizing agent for health-conscious consumers. Additionally, the expanding nutraceuticals sector is incorporating cyclodextrin into dietary supplements to enhance the absorption of bioactive compounds such as curcumin, resveratrol, and CoQ10.

Regulatory agencies, including the U.S. FDA and the European Food Safety Authority (EFSA), have approved various cyclodextrin derivatives for pharmaceutical and food applications, ensuring their safety and efficacy. Compliance with Good Manufacturing Practices (GMP) and stringent quality control standards has encouraged manufacturers to invest in high-purity cyclodextrin production. Furthermore, sustainability initiatives in the packaging and cosmetic industries are driving the development of cyclodextrin-based biodegradable coatings and encapsulation technologies.

What Is Driving the Growth of the Cyclodextrin Market?

The growth in the cyclodextrin market is driven by increasing applications in pharmaceuticals, functional foods, and cosmetics, alongside advancements in production technology. The rising prevalence of chronic diseases and the need for more effective drug formulations have accelerated the demand for cyclodextrin-based drug carriers. Additionally, the growing consumer preference for natural and sustainable ingredients has expanded cyclodextrin’s role in food preservation and cosmetic formulations.

End-use expansion is another key driver, with cyclodextrin being adopted in biotechnology, agriculture, and environmental remediation. The increasing use of cyclodextrin in controlled-release fertilizers and pesticide formulations has improved agricultural efficiency while reducing environmental impact. Moreover, research into cyclodextrin’s role in targeted therapy and biomedical imaging is opening new frontiers in healthcare innovation. As industries continue to seek high-performance excipients and delivery systems, the cyclodextrin market is poised for sustained growth, driven by technological advancements and expanding application areas.

Report Scope

The report analyzes the Cyclodextrin market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments: Type (Beta Cyclodextrin, Alpha Cyclodextrin, Gamma Cyclodextrin); Application (Pharmaceutical Application, Food and Beverages Application, Chemicals Application, Cosmetics and Personal Care Application)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Beta Cyclodextrin segment, which is expected to reach US$183.1 Million by 2030 with a CAGR of a 2.6%. The Alpha Cyclodextrin segment is also set to grow at 2.0% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $78.8 Million in 2024, and China, forecasted to grow at an impressive 4.4% CAGR to reach $62.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Cyclodextrin Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Cyclodextrin Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Cyclodextrin Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Ashland Global Holdings Inc., Bayer AG, Cayman Chemical Company, Cerestar USA Inc., Cyclo Therapeutics, Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 42 Featured):

• Ashland Global Holdings Inc.
• Bayer AG
• Cayman Chemical Company
• Cerestar USA Inc.
• Cyclo Therapeutics, Inc.
• Cyclodextrin-Shop
• Cyclolab
• Fengchen Group Co., Ltd.
• Ligand Pharmaceuticals Incorporated
• Merck KGaA
• Midas Pharma GmbH
• Otto Chemie Pvt. Ltd.
• Roquette Frères
• TCI Chemicals Pvt. Ltd.
• Tocris Bioscience
• VIO Chemicals
• Wacker Chemie AG
• Wellona Pharma
• Xi`an Deli Biochemical Industry Co., Ltd.
• Zibo Qianhui Biological Technology Co., Ltd.

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

• Tariff-adjusted market forecasts by region and segment
• Analysis of cost and supply chain implications by sourcing and trade exposure
• Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

• Finalized tariff impacts and new trade agreement effects
• Updated projections reflecting global sourcing and cost shifts
• Expanded country-specific coverage across the industry